Circulating Tumor Cell Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Circulating Tumor Cell Market to 2027 - Global Analysis and Forecasts by Technology (CTC Enrichment Methods, CTC Detection Methods, CTC Analysis); Application (Cancer stem cell research, EMT biomarkers development, Tumorgenesis research, Other applications.)

Report Code: TIPRE00004548 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Circulating Tumor Cell are the cells that have shed into the vasculature or lymphatic from a primary tumor and are carried around the body in the blood circulation.

MARKET DYNAMICS
The Circulating Tumor Cell Market is anticipated to grow in the forecast period owing to driving factors such as growing demand for faster diagnosis, innovation in CTC technology, high usage rates in biotechnology research establishments and high accuracy. Nevertheless, lack of awareness and reluctance to adopt the advanced CTC technologies may restrict the growth of market during the forecast period.

MARKET SCOPE
The "Global Circulating Tumor Cell Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global Market trend analysis. The report aims to provide an overview of Circulating Tumor Cell Market with detailed market segmentation by Technology, Application, and geography. The global Circulating Tumor Cell Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Circulating Tumor Cell Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Circulating Tumor Cell Market is segmented on the basis of Technology and Application. Based on Technology the market is segmented into CTC Enrichment Methods, CTC Detection Methods and CTC Analysis. Based on Application the market is segmented into Cancer stem cell research, EMT biomarkers development, Tumorgenesis research and other applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Circulating Tumor Cell Market based on various segments. It also provides Market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Circulating Tumor Cell Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Circulating Tumor Cell Market from both demand and supply side and further evaluates Market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Circulating Tumor Cell Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Circulating Tumor Cell Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the Market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Circulating Tumor Cell Market are anticipated to lucrative growth opportunities in the future with the rising demand for Circulating Tumor Cell in the global market. Below mentioned is the list of few companies engaged in the Circulating Tumor Cell Market.

The report also includes the profiles of key Circulating Tumor Cell Market companies along with their SWOT analysis and Market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Advanced Cell Diagnostics
  • Aviva Biosciences
  • Clearbridge BioMedics
  • Silicon Biosystems USA
  • Rarecells
  • Nanostring Technologies Inc.
  • Vitatex Inc
  • Fluxion Biosciences
  • Biofluidica
  • Adnagen AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Circulating Tumor Cell Market - By Technology
1.3.2 Circulating Tumor Cell Market - By Application
1.3.3 Circulating Tumor Cell Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CIRCULATING TUMOR CELL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CIRCULATING TUMOR CELL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CIRCULATING TUMOR CELL MARKET - GLOBAL MARKET ANALYSIS
6.1. CIRCULATING TUMOR CELL - GLOBAL MARKET OVERVIEW
6.2. CIRCULATING TUMOR CELL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CIRCULATING TUMOR CELL MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. CTC ENRICHMENT METHODS
7.3.1. Overview
7.3.2. CTC Enrichment Methods Market Forecast and Analysis
7.3.3. Ex vivo positive selection Market
7.3.3.1. Overview
7.3.3.2. Ex vivo positive selection Market Forecast and Analysis
7.3.4. In vivo positive selection Market
7.3.4.1. Overview
7.3.4.2. In vivo positive selection Market Forecast and Analysis
7.3.5. Negative selection Market
7.3.5.1. Overview
7.3.5.2. Negative selection Market Forecast and Analysis
7.3.6. Microchips Market
7.3.6.1. Overview
7.3.6.2. Microchips Market Forecast and Analysis
7.3.7. Single Spiral Microchannel Market
7.3.7.1. Overview
7.3.7.2. Single Spiral Microchannel Market Forecast and Analysis
7.4. CTC DETECTION METHODS
7.4.1. Overview
7.4.2. CTC Detection Methods Market Forecast and Analysis
7.4.3. Immunocytochemical Technologies Market
7.4.3.1. Overview
7.4.3.2. Immunocytochemical Technologies Market Forecast and Analysis
7.4.4. Molecular (RNA) based Technologies Market
7.4.4.1. Overview
7.4.4.2. Molecular (RNA) based Technologies Market Forecast and Analysis
7.4.5. Functional in vitro cell invasion assay Market
7.4.5.1. Overview
7.4.5.2. Functional in vitro cell invasion assay Market Forecast and Analysis
7.4.6. Xenotransplantation models Market
7.4.6.1. Overview
7.4.6.2. Xenotransplantation models Market Forecast and Analysis
7.5. CTC ANALYSIS
7.5.1. Overview
7.5.2. CTC Analysis Market Forecast and Analysis
8. CIRCULATING TUMOR CELL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER STEM CELL RESEARCH, EMT BIOMARKERS DEVELOPMENT, TUMORGENESIS RESEARCH, OTHER APPLICATIONS.
8.3.1. Overview
8.3.2. Cancer stem cell research, EMT biomarkers development, Tumorgenesis research, Other applications. Market Forecast and Analysis
9. CIRCULATING TUMOR CELL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Circulating Tumor Cell Market Overview
9.1.2 North America Circulating Tumor Cell Market Forecasts and Analysis
9.1.3 North America Circulating Tumor Cell Market Forecasts and Analysis - By Technology
9.1.4 North America Circulating Tumor Cell Market Forecasts and Analysis - By Application
9.1.5 North America Circulating Tumor Cell Market Forecasts and Analysis - By Countries
9.1.5.1 United States Circulating Tumor Cell Market
9.1.5.1.1 United States Circulating Tumor Cell Market by Technology
9.1.5.1.2 United States Circulating Tumor Cell Market by Application
9.1.5.2 Canada Circulating Tumor Cell Market
9.1.5.2.1 Canada Circulating Tumor Cell Market by Technology
9.1.5.2.2 Canada Circulating Tumor Cell Market by Application
9.1.5.3 Mexico Circulating Tumor Cell Market
9.1.5.3.1 Mexico Circulating Tumor Cell Market by Technology
9.1.5.3.2 Mexico Circulating Tumor Cell Market by Application
9.1.5.4 US Circulating Tumor Cell Market
9.1.5.4.1 US Circulating Tumor Cell Market by Technology
9.1.5.4.2 US Circulating Tumor Cell Market by Application
9.2. EUROPE
9.2.1 Europe Circulating Tumor Cell Market Overview
9.2.2 Europe Circulating Tumor Cell Market Forecasts and Analysis
9.2.3 Europe Circulating Tumor Cell Market Forecasts and Analysis - By Technology
9.2.4 Europe Circulating Tumor Cell Market Forecasts and Analysis - By Application
9.2.5 Europe Circulating Tumor Cell Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Circulating Tumor Cell Market
9.2.5.1.1 Germany Circulating Tumor Cell Market by Technology
9.2.5.1.2 Germany Circulating Tumor Cell Market by Application
9.2.5.2 France Circulating Tumor Cell Market
9.2.5.2.1 France Circulating Tumor Cell Market by Technology
9.2.5.2.2 France Circulating Tumor Cell Market by Application
9.2.5.3 Italy Circulating Tumor Cell Market
9.2.5.3.1 Italy Circulating Tumor Cell Market by Technology
9.2.5.3.2 Italy Circulating Tumor Cell Market by Application
9.2.5.4 Spain Circulating Tumor Cell Market
9.2.5.4.1 Spain Circulating Tumor Cell Market by Technology
9.2.5.4.2 Spain Circulating Tumor Cell Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Circulating Tumor Cell Market Overview
9.3.2 Asia-Pacific Circulating Tumor Cell Market Forecasts and Analysis
9.3.3 Asia-Pacific Circulating Tumor Cell Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Circulating Tumor Cell Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Circulating Tumor Cell Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Circulating Tumor Cell Market
9.3.5.1.1 Australia Circulating Tumor Cell Market by Technology
9.3.5.1.2 Australia Circulating Tumor Cell Market by Application
9.3.5.2 China Circulating Tumor Cell Market
9.3.5.2.1 China Circulating Tumor Cell Market by Technology
9.3.5.2.2 China Circulating Tumor Cell Market by Application
9.3.5.3 India Circulating Tumor Cell Market
9.3.5.3.1 India Circulating Tumor Cell Market by Technology
9.3.5.3.2 India Circulating Tumor Cell Market by Application
9.3.5.4 Japan Circulating Tumor Cell Market
9.3.5.4.1 Japan Circulating Tumor Cell Market by Technology
9.3.5.4.2 Japan Circulating Tumor Cell Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Circulating Tumor Cell Market Overview
9.4.2 Middle East and Africa Circulating Tumor Cell Market Forecasts and Analysis
9.4.3 Middle East and Africa Circulating Tumor Cell Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Circulating Tumor Cell Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Circulating Tumor Cell Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Circulating Tumor Cell Market
9.4.5.1.1 South Africa Circulating Tumor Cell Market by Technology
9.4.5.1.2 South Africa Circulating Tumor Cell Market by Application
9.4.5.2 Saudi Arabia Circulating Tumor Cell Market
9.4.5.2.1 Saudi Arabia Circulating Tumor Cell Market by Technology
9.4.5.2.2 Saudi Arabia Circulating Tumor Cell Market by Application
9.4.5.3 U.A.E Circulating Tumor Cell Market
9.4.5.3.1 U.A.E Circulating Tumor Cell Market by Technology
9.4.5.3.2 U.A.E Circulating Tumor Cell Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Circulating Tumor Cell Market Overview
9.5.2 South and Central America Circulating Tumor Cell Market Forecasts and Analysis
9.5.3 South and Central America Circulating Tumor Cell Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Circulating Tumor Cell Market Forecasts and Analysis - By Application
9.5.5 South and Central America Circulating Tumor Cell Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Circulating Tumor Cell Market
9.5.5.1.1 Brazil Circulating Tumor Cell Market by Technology
9.5.5.1.2 Brazil Circulating Tumor Cell Market by Application
9.5.5.2 Argentina Circulating Tumor Cell Market
9.5.5.2.1 Argentina Circulating Tumor Cell Market by Technology
9.5.5.2.2 Argentina Circulating Tumor Cell Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CIRCULATING TUMOR CELL MARKET, KEY COMPANY PROFILES
11.1. ADVANCED CELL DIAGNOSTICS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AVIVA BIOSCIENCES
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CLEARBRIDGE BIOMEDICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SILICON BIOSYSTEMS USA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. RARECELLS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NANOSTRING TECHNOLOGIES INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. VITATEX INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. FLUXION BIOSCIENCES
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BIOFLUIDICA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ADNAGEN AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Advanced Cell Diagnostics
- Aviva Biosciences
- Clearbridge BioMedics
- Silicon Biosystems USA
- Rarecells
- Nanostring Technologies Inc.
- Vitatex Inc
- Fluxion Biosciences
- Biofluidica
- Adnagen AG
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book